Neopterin: A mediator of the cellular immune system

Pteridines

Volumn 15, Issue 3, 2004, Pages 107-112

  Hoffmann, Georg ^a   Schobersberger, Wolfgang ^a  

^a UNIVERSITY FOR HEALTH SCIENCES   (Austria)

Author keywords

Infection; Inflammation; Neopterin; Oxidative stress

Indexed keywords

ADENOSINE TRIPHOSPHATE; BACTERIUM LIPOPOLYSACCHARIDE; CYTOKINE; ERYTHROPOIETIN; HYDROXYL RADICAL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; NEOPTERIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; REACTIVE NITROGEN SPECIES; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TOSYLCHLORAMIDE SODIUM; TRANSFERRIN; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; INFECTION; INFLAMMATION; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SYNTHESIS;

BACTERIA (MICROORGANISMS);

EID: 4644313685     PISSN: 09334807     EISSN: 21954720     Source Type: Journal    
DOI: 10.1515/pteridines.2004.15.3.107     Document Type: Review

References (37)

1. Sakurai A, Goto M. Neopterin: isolation from human urine. J Biochem (Tokyo) 1967; 61: 142-145.
2. Fuchs D, Granditsch G, Hausen A, Reibnegger G, Wachter H. Urinary neopterin excretion in coeliac disease. Lancet 1983; 2: 463-464.
3. Fuchs D, Hausen A, Kofler M, Kosanowski H, Reibnegger G, Wachter H. Neopterin as an index of immune response in patients with tuberculosis. Lung 1984; 162: 337-346.
4. Fuchs D, Spira TJ, Hausen A, et al. Neopterin as a predictive marker for disease progression in human immunodeficiency virus type 1 infection. Clin Chem 1989; 35: 1746-1749.
5. Honlinger M, Fuchs D, Hausen A, et al. [Serum neopterin determination for the additional safeguarding of blood transfusions. Our experiences with 76,587 blood donors]. Dtsch Med Wochenschr 1989; 114: 172-176.
6. Wachter H, Hausen A, Grassmayr K. [Increased urinary excretion of neopterin in patients with malignant tumors and with virus diseases (author's transl)]. Hoppe Seylers Z Physiol Chem 1979; 360: 1957-1960.
7. Kojima S, Icho T, Mori H, Arai T. Enhancing potency of neopterin toward B-16 melanoma cell damage induced by UV-A irradiation and its possible application for skin tumor treatment. Anticancer Res 1995; 15: 1975-1980.
8. Murr C, Fuchs D, Gossler W, et al. Enhancement of hydrogen peroxide-induced luminol-dependent chemiluminescence by neopterin depends on the presence of iron chelator complexes. FEBS Lett 1994; 338: 223-226.
9. Weiss G, Fuchs D, Hausen A, et al. Neopterin modulates toxicity mediated by reactive oxygen and chloride species. FEBS Lett 1993; 321: 89-92.
10. Strohmaier W, Redl H, Schlag G, Inthorn D. D-erythro-neopterin plasma levels in intensive care patients with and without septic complications. Crit Care Med 1987; 15: 757-760.
11. Hoffmann G, Schobersberger W, Frede S, et al. Neopterin activates transcription factor nuclear factor-kappa B in vascular smooth muscle cells. FEBS Lett 1996; 391: 181-184.
12. Schobersberger W, Hoffmann G, Grote J, Wachter H, Fuchs D. Induction of inducible nitric oxide synthase expression by neopterin in vascular smooth muscle cells. FEBS Lett 1995; 377: 461-464.
13. Beutler B, Grau GE. Tumor necrosis factor in the pathogenesis of infectious diseases. Crit Care Med 1993; 21: S423-S435.
14. Offner F, Philippe J, Vogelaers D, et al. Serum tumor necrosis factor levels in patients with infectious disease and septic shock. J Lab Clin Med 1990; 116: 100-105.
15. Barak M, Gruener N. Neopterin augmentation of tumor necrosis factor production. Immunol Lett 1991; 30: 101-106.
16. Hoffmann G, Frede S, Kenn S, et al. Neopterin-induced tumor necrosis factor-alpha synthesis in vascular smooth muscle cells in vitro. Int Arch Allergy Immunol 1998; 116: 240-245.
17. Margreiter J, Schlager A, Balogh A, et al. Exogenous neopterin causes cardiac contractile dysfunction in the isolated perfused rat heart. J Mol Cell Cardiol 2000; 32: 1265-1274.
18. Hoffmann G, Kenn S, Wirleitner B, et al. Neopterin induces nitric oxide-dependent apoptosis in rat vascular smooth muscle cells. Immunobiology 1998; 199: 63-73.
19. Buttery LD, Springall DR, Chester AH, et al. Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. Lab Invest 1996; 75: 77-85.
20. Herpfer I, Greilberger J, Ledinski G, Widner B, Fuchs D, Jurgens G. Neopterin and 7,8-dihydroneopterin interfere with low density lipoprotein oxidation mediated by peroxynitrite and/or copper. Free Radic Res 2002; 36: 509-520.
21. Weiss G, Willeit J, Kiechl S, et al. Increased concentrations of neopterin in carotid atherosclerosis. Atherosclerosis 1994; 106: 263-271.
22. Schobersberger W, Hoffmann G, Hobisch-Hagen P, et al. Neopterin and 7,8-dihydroneopterin induce apoptosis in the rat alveolar epithelial cell line L2. FEBS Lett 1996; 397: 263-268.
23. Compton CN, Franko AP, Murray MT, Diebel LN, Dulchavsky SA. Signaling of apoptotic lung injury by lipid hydroperoxides. J Trauma 1998; 44: 783-788.
24. Hoffmann G, Rieder J, Smolny M, et al. Neopterin-induced expression of intercellular adhesion molecule-1 (ICAM-1) in type II-like alveolar epithelial cells. Clin Exp Immunol 1999; 118: 435-440.
25. Baumer I, Zissel G, Schlaak M, Muller-Quernheim J. Shed soluble ICAM-1 molecules in bronchoalveolar lavage cell supernatants and serum of patients with pulmonary sarcoidosis. Lung 1997; 175: 105-116.
26. Schobersberger W, Hobisch-Hagen P, Hoffmann G, Fuchs D. Erythropoietin response and cytokines in critically ill patients. Intensive Care Med 1997; 23: 920.
27. Schobersberger W, Hobisch-Hagen P, Fuchs D, Hoffmann G, Jelkmann W. Pathogenesis of anaemia in the critically ill patient. Crit Int Care 1998; 9: 111-117.
28. Faquin WC, Schneider TJ, Goldberg MA. Effect of inflammatory cytokines on hypoxia-induced erythropoietin production. Blood 1992; 79: 1987-1994.
29. Jelkmann W, Pagel H, Wolff M, Fandrey J. Monokines inhibiting erythropoietin production in human hepatoma cultures and in isolated perfused rat kidneys. Life Sci 1992; 50: 301-308.
30. Udupa KB, Lipschitz DA. Endotoxin-induced suppression of erythropoiesis: the role of erythropoietin and a heme synthesis stimulating factor. Blood 1982; 59: 1267-1271.
31. Fuchs D, Zangerle R, Artner-Dworzak E, et al. Association between immune activation, changes of iron metabolism and anaemia in patients with HIV infection. Eur J Haematol 1993; 50: 90-94.
32. Denz H, Huber P, Landmann R, Orth B, Wachter H, Fuchs D. Association between the activation of macrophages, changes of iron metabolism and the degree of anaemia in patients with malignant disorders. Eur J Haematol 1992; 48: 244-248.
33. Schobersberger W, Jelkmann W, Fandrey F, Frede S, Wachter H, Fuchs D. Neopterin-induced suppression of erythropoietin production in vitro. Pteridines 1995; 8: 12-16.
34. Pagel H, Fandrey J, Schobersberger W, Fuchs D, Jelkmann W. Effects of neopterin and 7,8-dihydroneopterin on hypoxia-induced renal erythropoietin production. Eur J Haematol 1999; 62: 341-345.
35. Pagel H, Hoffmann G, Fuchs D, Schobersberger W. On the mechanisms of the neopterin-induced suppression of renal erythropoietin production. Pteridines 2004; 15: 28-32.
36. Woll E, Weiss G, Fuchs D, Lang F, Wachter H. Effect of pteridine derivatives on intracellular calcium concentration in human monocytic cells. FEBS Lett 1993; 318: 249-252.
37. Hoffmann G, Gollnick F, Meyer R. Neopterin inhibits ATP-induced calcium release in alveolar epithelial cells in vitro. Mediators Inflamm 2002; 11: 181-185.